APA (7th ed.) Citation

Dolce, D., Francalanci, M., Orioli, T., Campana, S., Ravenni, N., Camera, E., . . . Taccetti, G. (2024). WS09.02 Biomarkers for monitoring the effect of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis. Journal of Cystic Fibrosis, 23, S16. https://doi.org/10.1016/S1569-1993(24)00159-0

Chicago Style (17th ed.) Citation

Dolce, D., et al. "WS09.02 Biomarkers for Monitoring the Effect of Elexacaftor/tezacaftor/ivacaftor Treatment in People with Cystic Fibrosis." Journal of Cystic Fibrosis 23 (2024): S16. https://doi.org/10.1016/S1569-1993(24)00159-0.

MLA (9th ed.) Citation

Dolce, D., et al. "WS09.02 Biomarkers for Monitoring the Effect of Elexacaftor/tezacaftor/ivacaftor Treatment in People with Cystic Fibrosis." Journal of Cystic Fibrosis, vol. 23, 2024, p. S16, https://doi.org/10.1016/S1569-1993(24)00159-0.